AllianceBernstein’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,956,087
Closed -$194M 3205
2019
Q3
$194M Sell
1,956,087
-61,728
-3% -$5.87M 0.12% 153
2019
Q2
$187M Sell
2,017,815
-2,145,303
-52% -$204M 0.12% 162
2019
Q1
$393M Sell
4,163,118
-110,087
-3% -$9.63M 0.26% 87
2018
Q4
$274M Buy
4,273,205
+76,169
+2% +$5.62M 0.2% 104
2018
Q3
$376M Buy
4,197,036
+231,231
+6% +$20.4M 0.25% 89
2018
Q2
$315M Buy
3,965,805
+520,831
+15% +$43.2M 0.22% 101
2018
Q1
$307M Buy
3,444,974
+316,946
+10% +$30.4M 0.22% 99
2017
Q4
$326M Buy
3,128,028
+5,309
+0.2% +$599K 0.23% 98
2017
Q3
$455M Buy
3,122,719
+10,617
+0.3% +$1.45M 0.34% 69
2017
Q2
$404M Sell
3,112,102
-37,741
-1% -$4.62M 0.31% 75
2017
Q1
$392M Sell
3,149,843
-33,533
-1% -$4.01M 0.31% 75
2016
Q4
$368M Sell
3,183,376
-143,736
-4% -$16M 0.31% 72
2016
Q3
$348M Buy
3,327,112
+325,653
+11% +$35.2M 0.29% 81
2016
Q2
$296M Buy
3,001,459
+47,665
+2% +$4.93M 0.25% 88
2016
Q1
$296M Buy
2,953,794
+22,014
+0.8% +$2.27M 0.25% 98
2015
Q4
$351M Buy
2,931,780
+9,630
+0.3% +$1.11M 0.3% 76
2015
Q3
$316M Buy
2,922,150
+271,101
+10% +$33.6M 0.27% 88
2015
Q2
$307M Sell
2,651,049
-367,309
-12% -$42M 0.25% 93
2015
Q1
$348M Sell
3,018,358
-313,431
-9% -$37.5M 0.28% 84
2014
Q4
$373M Sell
3,331,789
-710,969
-18% -$75M 0.31% 80
2014
Q3
$383M Sell
4,042,758
-357,412
-8% -$32.3M 0.32% 75
2014
Q2
$378M Sell
4,400,170
-420,420
-9% -$32M 0.32% 71
2014
Q1
$336M Sell
4,820,590
-1,940,714
-29% -$154M 0.29% 82
2013
Q4
$571M Buy
6,761,304
+1,640,640
+32% +$130M 0.51% 40
2013
Q3
$394M Sell
5,120,664
-212,856
-4% -$14.9M 0.39% 60
2013
Q2
$312M Buy
+5,333,520
New +$321M 0.33% 77

Other funds holding CELG

AllianceBernstein's CELG Position: Q4 2019 in Review

AllianceBernstein sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,956,087 shares — an estimated $194M sold.

AllianceBernstein first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $571M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • AllianceBernstein reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • AllianceBernstein sold 1,956,087 Celgene Corp shares in Q4 2019, an estimated $194M.
  • AllianceBernstein first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • AllianceBernstein's Celgene Corp position peaked at $571M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.